Assembly 11: Video-Assisted Thoracoscopic or Open Lobectomy in Early-Stage Lung Cancer (VIOLET study)
Date/Time: 17 November 2022 at 18:00–19:00 CET
Topic: This month’s journal club session will explore the article "Video-Assisted Thoracoscopic or Open Lobectomy in Early-Stage Lung Cancer"
Ref Article: NEJM Evid 2022; 1 (3). DOI: https://doi.org/10.1056/EVIDoa2100016
Facilitators: Dr. Beenish Iqbal (London, United Kingdom), Prof. Najib Rahman (Oxford, United Kingdom)
Assembly 11: Evolving Molecular Tests for Mesothelioma: More or Less Clear?
Date/Time: 30 June 2022 at 17:00–18:00 CET.
Topic: This month’s journal club session will explore the article “Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma”
Ref Article: Modern Pathology 2022. https://doi.org/10.1038/s41379-022-01081-z
Presenter: Dr. Selina Tsim (Glasgow, United Kingdom)
Facilitators: Prof. Kevin Blyth (Glasgow, United Kingdom)
Assembly 11: IO in SCLC
Date/Time: 26 May 2022 at 17:00–18:00 CET.
Topic: This month’s journal club session will explore the Lancet article “Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN)”
Ref Article: Lancet Oncol 2021; 22:51-56
Presenter: Dr. Pinelopi Schoini (Cholargos, Greece)
Facilitators: Dr. Andriani Charpidou (Athens, Greece)
 | IO in SCLC
Pinelopi Schoini (Cholargos, Greece) & Andriani Charpidou (Athens, Greece)
Open |
Assembly 11: Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer
Date/Time: 28 April 2022 at 17:00–18:00 CET.
Topic: This month’s journal club session will explore the Lancet article “Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial”
Ref Article: Lancet 2021 9;398(10308):1344-1357
DOI: 10.1016/S0140-6736(21)02098-5.
Facilitators: Maria Joana Pereira and Daniela Rodrigues
Assembly 11: Thoracic oncology - Sotorasib for Lung Cancers with KRAS p.G12C Mutation
Date/Time: 31 Mar 2022 at 17:00–18:00 CET.
Topic: This month’s journal club session will explore the NEJM article “Sotorasib for Lung Cancers with KRAS p.G12C Mutation”
Ref Article: N Engl J Med 2021; 384:2371-2381
DOI: 10.1056/NEJMoa2103695.
Facilitators: Dr Anneloes Noordhof and Dr Wouter H. van Geffen
Assembly 11: Thoracic oncology - Mesothelioma
Date/Time: 10 Mar 2022 at 17:00–18:00 CET.
Topic: Tthis journal club will explore a major randomised trial in mesothelioma treatment, implications for practice and the strengths and weaknesses of the study in the context of the published data.
Facilitators: Dr Dinesh Addala (Oxford) & Najib Rahman, Professor of Respiratory Medicine, University of Oxford / Secretary of ERS Assembly 11: Thoracic oncology.